Spectral Med Price To Earning vs. Cash Per Share

EDT Stock  CAD 0.55  0.01  1.79%   
Based on the measurements of profitability obtained from Spectral Med's financial statements, Spectral Med's profitability may be sliding down. It has an above-average odds of reporting lower numbers next quarter. Profitability indicators assess Spectral Med's ability to earn profits and add value for shareholders. At this time, Spectral Med's EV To Sales is very stable compared to the past year. As of the 4th of December 2024, Sales General And Administrative To Revenue is likely to grow to 7.22, while Price To Sales Ratio is likely to drop 45.68. At this time, Spectral Med's Accumulated Other Comprehensive Income is very stable compared to the past year. As of the 4th of December 2024, Income Tax Expense is likely to grow to about 162.8 K, while Operating Income is likely to drop (12 M).
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.780.4143
Way Up
Slightly volatile
For Spectral Med profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Spectral Med to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Spectral Med utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Spectral Med's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Spectral Med over time as well as its relative position and ranking within its peers.
  
Check out Investing Opportunities.
Please note, there is a significant difference between Spectral Med's value and its price as these two are different measures arrived at by different means. Investors typically determine if Spectral Med is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Spectral Med's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Spectral Med Cash Per Share vs. Price To Earning Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Spectral Med's current stock value. Our valuation model uses many indicators to compare Spectral Med value to that of its competitors to determine the firm's financial worth.
Spectral Med is one of the top stocks in price to earning category among its peers. It also is one of the top stocks in cash per share category among its peers . At this time, Spectral Med's Cash Per Share is very stable compared to the past year. Comparative valuation analysis is a catch-all model that can be used if you cannot value Spectral Med by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Spectral Med's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

Spectral Cash Per Share vs. Price To Earning

Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.

Spectral Med

P/E

 = 

Market Value Per Share

Earnings Per Share

 = 
(16.07) X
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.

Spectral Med

Cash Per Share

 = 

Total Cash

Average Shares

 = 
0.02 X
Companies with high Cash per Share ratio will be considered as an attractive investment by most investors. In most industries if you can single out an equity instrument trading below its cash per share value, you have a bargain and should consider buying it. Finding the stocks traded below their cash value, therefore, can be a good starting point for investors using strategies based on fundamentals.

Spectral Cash Per Share Comparison

Spectral Med is currently under evaluation in cash per share category among its peers.

Spectral Med Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Spectral Med, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Spectral Med will eventually generate negative long term returns. The profitability progress is the general direction of Spectral Med's change in net profit over the period of time. It can combine multiple indicators of Spectral Med, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income12.9 M13.6 M
Operating Income-11.4 M-12 M
Net Loss-15.7 M-14.9 M
Income Tax Expense155 K162.8 K
Income Before Tax-15.5 M-14.7 M
Total Other Income Expense Net-4.1 M-3.9 M
Net Loss-15.5 M-14.7 M
Net Loss-12.9 M-13.6 M
Interest Income72.9 K46.4 K
Net Interest Income-1.3 M-1.3 M
Change To Netincome449.6 K675.4 K
Net Loss(0.06)(0.06)
Income Quality 0.68  0.84 
Net Income Per E B T 1.01  1.32 

Spectral Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Spectral Med. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Spectral Med position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Spectral Med's important profitability drivers and their relationship over time.

Use Spectral Med in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Spectral Med position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Spectral Med will appreciate offsetting losses from the drop in the long position's value.

Spectral Med Pair Trading

Spectral Med Pair Trading Analysis

The ability to find closely correlated positions to Spectral Med could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Spectral Med when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Spectral Med - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Spectral Med to buy it.
The correlation of Spectral Med is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Spectral Med moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Spectral Med moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Spectral Med can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Spectral Med position

In addition to having Spectral Med in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Beers Thematic Idea Now

Beers
Beers Theme
Companies involved in production and distribution of domestic and international beer. The Beers theme has 48 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Beers Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in Spectral Stock

To fully project Spectral Med's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Spectral Med at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Spectral Med's income statement, its balance sheet, and the statement of cash flows.
Potential Spectral Med investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Spectral Med investors may work on each financial statement separately, they are all related. The changes in Spectral Med's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Spectral Med's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.